These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10680732)

  • 81. [Epidemiology of prostate cancer: recent results from the Epidemiological Cancer Register of the District of Münster (Germany)].
    Kraywinkel K; Lehnert M; Semjonow A; Hense HW
    Urologe A; 2008 Jul; 47(7):853-9. PubMed ID: 18398595
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Randomized studies of PSA screening: an opinion.
    Sartor O
    Asian J Androl; 2011 May; 13(3):364-5. PubMed ID: 21358665
    [No Abstract]   [Full Text] [Related]  

  • 83. Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements.
    Zitricky F; Försti A; Hemminki A; Hemminki O; Hemminki K
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627160
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Epidemiological Study of Prostate Cancer in the Province of Salamanca (2006-2015).
    Bartolomé Gutiérrez JS; Abad AS; Domínguez FS; Ludeña de la Cruz MD; Hernández JJC
    Arch Esp Urol; 2022 Sep; 75(7):630-637. PubMed ID: 36214145
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The impact of the demographic shift on limb amputation incidence in Saskatchewan, Canada, 2006-2019.
    Essien SK; Zucker-Levin A
    PLoS One; 2022; 17(9):e0274037. PubMed ID: 36054197
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Radical prostatectomies in Austria, 1997-2004.
    Haidinger G; Madersbacher S; Schatzl G; Vutuc C
    BMC Res Notes; 2008 Jul; 1():48. PubMed ID: 18710501
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Why is prostate cancer incidence rising in young men?
    Sartor O
    Cancer; 2020 Jan; 126(1):17-18. PubMed ID: 31553480
    [No Abstract]   [Full Text] [Related]  

  • 88. Trends in prostate cancer incidence and mortality in Canada during the era of prostate-specific antigen screening.
    Dickinson J; Shane A; Tonelli M; Connor Gorber S; Joffres M; Singh H; Bell N
    CMAJ Open; 2016; 4(1):E73-9. PubMed ID: 27280117
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study.
    Mahmud SM; Franco EL; Turner D; Platt RW; Beck P; Skarsgard D; Tonita J; Sharpe C; Aprikian AG
    PLoS One; 2011 Jan; 6(1):e16412. PubMed ID: 21297996
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Trends in prostate cancer incidence, hospital utilization and surgical procedures, Canada, 1981-2000.
    Neutel CI; Gao RN; Blood PA; Gaudette LA
    Can J Public Health; 2006; 97(3):177-82. PubMed ID: 16827401
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence.
    Hayes JH; Barry MJ
    JAMA; 2014 Mar; 311(11):1143-9. PubMed ID: 24643604
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Impact of screening on prostate cancer rates and trends.
    Mettlin C
    Microsc Res Tech; 2000 Dec; 51(5):415-8. PubMed ID: 11074610
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Prostate cancer in Saskatchewan Canada, before and during the PSA era.
    Skarsgard D; Tonita J
    Cancer Causes Control; 2000 Jan; 11(1):79-88. PubMed ID: 10680732
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Changes in case mix and treatment patterns in prostate cancer in Saskatchewan during the prostate specific antigen testing era.
    Tonita JM; Skarsgard D; Muhajarine N
    Cancer Causes Control; 2009 Mar; 20(2):201-9. PubMed ID: 18825504
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
    Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?
    Valberg M; Grotmol T; Tretli S; Veierød MB; Moger TA; Devesa SS; Aalen OO
    Eur J Epidemiol; 2017 Jun; 32(6):511-520. PubMed ID: 27431530
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.